IOBTIO Biotech, Inc.

Nasdaq iobiotech.com


$ 1.40 $ -0.03 (-2.07 %)    

Friday, 26-Apr-2024 15:59:57 EDT
QQQ $ 431.01 $ 6.55 (1.54 %)
DIA $ 382.27 $ 1.39 (0.36 %)
SPY $ 508.26 $ 4.77 (0.95 %)
TLT $ 88.26 $ 0.46 (0.52 %)
GLD $ 216.60 $ 0.70 (0.32 %)
$ 1.42
$ 1.43
$ 0.00 x 0
$ 0.00 x 0
$ 1.40 - $ 1.43
$ 0.82 - $ 2.64
73,378
na
61.83M
$ 1.18
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 03-05-2024 12-31-2023 10-K
2 11-13-2023 09-30-2023 10-Q
3 08-11-2023 06-30-2023 10-Q
4 05-11-2023 03-31-2023 10-Q
5 03-14-2023 12-31-2022 10-K
6 11-09-2022 09-30-2022 10-Q
7 08-11-2022 06-30-2022 10-Q
8 05-16-2022 03-31-2022 10-Q
9 03-31-2022 12-31-2021 10-K
10 12-17-2021 09-30-2021 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 hc-wainwright--co-reiterates-buy-on-io-biotech-maintains-8-price-target

HC Wainwright & Co. analyst Emily Bodnar reiterates IO Biotech (NASDAQ:IOBT) with a Buy and maintains $8 price target.

 io-biotech-q4-eps-040-misses-039-estimate

IO Biotech (NASDAQ:IOBT) reported quarterly losses of $(0.40) per share which missed the analyst consensus estimate of $(0.39) ...

 top-5-health-care-stocks-that-may-crash-this-month

As of Jan. 22, 2024, five stocks in the health care sector could be flashing a real warning to investors who value momentum as ...

 io-biotech-announces-first-patient-dosed-in-phase-2-neoadjuvantadjuvant-solid-tumor-basket-trial

IO Biotech (NASDAQ:IOBT), a clinical-stage biopharmaceutical company developing novel, immune modulating therapeutic cancer vac...

 why-anavex-life-sciences-shares-are-trading-lower-by-around-10-here-are-other-stocks-moving-in-mondays-mid-day-session

Shares of Anavex Life Sciences Corp. (NASDAQ: AVXL) moved lower during Monday’s session after the company reported fourth-quart...

 io-biotech-and-2-other-stocks-under-2-insiders-are-buying

The Dow Jones closed higher by over 100 points on Friday. When insiders purchase or sell shares, it indicates their confidence ...

 io-biotech-q3-eps-043-beats-044-estimate

IO Biotech (NASDAQ:IOBT) reported quarterly losses of $(0.43) per share which beat the analyst consensus estimate of $(0.44) by...

 io-biotech-q3-earnings-insights
IO Biotech: Q3 Earnings Insights
11/13/2023 13:15:06

 expert-ratings-for-io-biotech
Expert Ratings for IO Biotech
09/28/2023 15:00:51

 piper-sandler-initiates-coverage-on-io-biotech-with-overweight-rating-announces-price-target-of-10

Piper Sandler analyst Christopher Raymond initiates coverage on IO Biotech (NASDAQ:IOBT) with a Overweight rating and announ...

 hc-wainwright--co-reiterates-buy-on-io-biotech-maintains-8-price-target

HC Wainwright & Co. analyst Emily Bodnar reiterates IO Biotech (NASDAQ:IOBT) with a Buy and maintains $8 price target.

 morgan-stanley-maintains-overweight-on-io-biotech-lowers-price-target-to-7

Morgan Stanley analyst Matthew Harrison maintains IO Biotech (NASDAQ:IOBT) with a Overweight and lowers the price target fro...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION